UAE digital health startups raised $480M since 2022, with 7 companies now at scale

The UAE's digital health sector has attracted more than $480 million in venture funding since 2022. Seven companies now operate at a scale where their platforms touch millions of patient interactions annually across Dubai, Abu Dhabi, and the Northern Emirates.

The companies pulling ahead

Okadoc, the Abu Dhabi-based appointment and patient engagement platform, processes over 5 million bookings annually across 300+ healthcare facilities. The company raised $10 million in its Series B and has integrated with the Department of Health Abu Dhabi (DOH) Malaffi health information exchange, giving it a data pipeline that competitors lack.

Nabta Health, focused on women's health diagnostics, has expanded its at-home testing kits to cover 40+ biomarkers and operates across the UAE and Saudi Arabia. The company secured $4 million in funding and partners with insurance providers to offer employer-sponsored screening programs.

Altibbi, originally a Jordanian telemedicine platform, now runs a significant portion of its consultations through UAE-based physicians. The platform reported 2.8 million consultations across the MENA region in 2025 and holds a Dubai Health Authority (DHA) telemedicine license. Vezeeta, the Cairo-founded booking platform, has built a UAE patient base exceeding 1.2 million users and added e-pharmacy fulfillment in Dubai during late 2025.

Health at Hand operates as one of the earliest DHA-licensed virtual care providers. Praava Health has combined physical clinics with digital triage in a hybrid model that appeals to insurers seeking lower per-visit costs.

Cura, the Saudi-UAE telehealth app, crossed 1.5 million registered users in the Gulf and is a primary care gateway, routing patients to in-person specialists when virtual consultations reach their clinical limits.

Regulation that moved the market

The DHA issued updated telemedicine guidelines in 2025 that expanded the scope of virtual prescribing, allowing physicians to issue 90-day prescriptions for chronic conditions via video consultations. Licensed platform operators reported that this single change increased their recurring telemedicine revenue by 15–20%.

The DOH went further with its Malaffi mandate, requiring all Abu Dhabi-licensed facilities to share patient records through the centralized exchange by Q2 2025. Startups that integrated early gained access to longitudinal patient data. Those that delayed faced license renewal complications.

MOHAP published a consultation paper in late 2025 outlining a unified federal digital health framework for the Northern Emirates, where telehealth accounts for below 8% of total consultations compared to 22% in Dubai. That gap is both a regulatory problem and a commercial opportunity for startups willing to operate outside the two main emirates.

Where investor capital is heading in 2026

Four subsectors are attracting the most attention from health tech investors this year:

• AI-assisted diagnostics: radiology and pathology platforms that reduce reporting turnaround from days to hours, with at least four UAE-based startups in active fundraising rounds
• Revenue cycle management: tools that automate insurance claims processing, where UAE hospitals lose an estimated AED 2.1 billion annually to claim denials and coding errors
• Remote patient monitoring: wearable-integrated platforms for chronic disease management, driven by DHA's target to reduce hospital readmission rates by 12% before 2027
• Mental health platforms: digital therapy and counselling apps targeting the 28% year-on-year growth in mental health consultations recorded across Dubai facilities

The UAE has 12,500+ licensed healthcare facilities, a population that skews young and digitally native, and regulators who have adjusted frameworks quickly when evidence supported it. For startup founders, the constraint is no longer market access. It is execution speed against well-funded hospital groups like Pure Health and Aster DM Healthcare that are building competing digital capabilities in-house.

The next 18 months will separate startups that convert pilot contracts into enterprise agreements from those stuck in the proof-of-concept phase that stalled earlier waves of UAE health tech companies.